Viewing StudyNCT00005869



Ignite Creation Date: 2024-05-05 @ 10:17 AM
Last Modification Date: 2024-10-26 @ 9:05 AM
Study NCT ID: NCT00005869
Status: UNKNOWN
Last Update Posted: 2013-12-04
First Post: 2000-06-02

Brief Title: Nitrocamptothecin Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer
Sponsor: Astex Pharmaceuticals Inc
Organization: National Cancer Institute NCI

Conditions & Keywords Data

Conditions:
Name
Pancreatic Cancer
Keywords:
Name View
stage IV pancreatic cancer View
stage II pancreatic cancer View
stage III pancreatic cancer View
recurrent pancreatic cancer View
adenocarcinoma of the pancreas View